These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28616428)

  • 1. Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients.
    Siavash M; Tabbakhian M; Sabzghabaee AM; Razavi N
    J Res Pharm Pract; 2017; 6(2):73-76. PubMed ID: 28616428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
    Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
    Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Diversity of Metformin Related Gastrointestinal Side Effects.
    Saluja M; Pareek KK; Swami YK
    J Assoc Physicians India; 2020 Aug; 68(8):36-38. PubMed ID: 32738838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients.
    Guo L; Guo X; Li Y; Hong X; Jiang X; Su Q; Zhao D; Wu X; Ji L
    Diabetes Metab Syndr; 2016; 10(3):137-42. PubMed ID: 26948203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study.
    Kumar KMP; Chawla M; Sanghvi A; Sastry NG; Kotla C; Phatak S; Choudhari S
    Int J Gen Med; 2019; 12():147-159. PubMed ID: 31040711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.
    Al Omari M; Khader Y; Dauod AS; Beni Yonis OA; Khassawneh AH
    J Drug Assess; 2016; 5(1):29-33. PubMed ID: 27994943
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment satisfaction with ITCA 650, a novel drug-device delivering continuous exenatide, versus twice-daily injections of exenatide in type 2 diabetics using metformin.
    Henry R; Rosenstock J; McCarthy JF; Carls G; Alessi T; Yee J; Baron M
    Diabetes Obes Metab; 2018 Mar; 20(3):638-645. PubMed ID: 29053202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
    Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
    Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
    Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
    Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulation.
    Mtambo A; Harris M; Toy J; Guillemi S; Zhang W; Lima VD; Hogg R; Montaner JS; Hull M
    Curr HIV Res; 2013 Apr; 11(3):231-7. PubMed ID: 24010147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose Comparison And Side Effect Profile Of Metformin Extended Release Versus Metformin Immediate Release.
    Hameed M; Khan K; Salman S; Mehmood N
    J Ayub Med Coll Abbottabad; 2017; 29(2):225-229. PubMed ID: 28718236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.
    Burton JH; Johnson M; Johnson J; Hsia DS; Greenway FL; Heiman ML
    J Diabetes Sci Technol; 2015 Jul; 9(4):808-14. PubMed ID: 25802471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron and metformin-induced gastrointestinal side effects.
    Hoffmann IS; Roa M; Torrico F; Cubeddu LX
    Am J Ther; 2003; 10(6):447-51. PubMed ID: 14624284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study.
    Lüdemann J; Dütting ED; Dworak M
    Ther Adv Endocrinol Metab; 2015 Aug; 6(4):141-8. PubMed ID: 26301063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes.
    Huang Y; Sun J; Wang X; Tao X; Wang H; Tan W
    J Clin Pharm Ther; 2015 Aug; 40(4):461-5. PubMed ID: 26032654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.
    Mima Y; Kuwashiro T; Yasaka M; Tsurusaki Y; Nakamura A; Wakugawa Y; Okada Y
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):436-46. PubMed ID: 26725260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Severity of Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with a Sulfonylurea-Based Regimen at University-Affiliated Hospitals in Korea: The Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects Study.
    Kim YS; Cho BL; Kim WS; Kim SH; Jung IH; Sin WY; Choi DH; Lee SJ; Lim CS; Kang KP; Yu BY; Jeung W; Park CG
    Korean J Fam Med; 2019 Jul; 40(4):212-219. PubMed ID: 31344994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.
    Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V;
    Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.